SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-069497
Filing Date
2023-06-08
Accepted
2023-06-08 18:13:51
Documents
1
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2318219-2_4seq.html 4  
1 OWNERSHIP DOCUMENT tm2318219-2_4seq.xml 4 4035
  Complete submission text file 0001104659-23-069497.txt   5596
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 158 FILMORE STREET DENVER CO 80206
Business Address
Ugwumba Chidozie (Reporting) CIK: 0001835544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 231003284